EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:77119 - EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor
| ChEBI ID | CHEBI:77119 |
| ChEBI Name | EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor |
| Stars | |
| ASCII Name | EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor |
| Definition | An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that interferes with the action of prostaglandin-E2 9-reductase (EC 1.1.1.189). |
| Last Modified | 27 January 2014 |
| Submitter | Gareth Owen |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor (CHEBI:77119) is a EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor (CHEBI:76835) |
| Incoming Relation(s) |
| hexadecanoic acid (CHEBI:15756) has role EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor (CHEBI:77119) |
| Synonyms | Source |
|---|---|
| PGE2 9-oxoreductase inhibitor | ChEBI |
| PGE-9-ketoreductase inhibitors | ChEBI |
| (5Z,13E)-(15S)-9α,11α,15-trihydroxyprosta-5,13-dienoate:NADP+ 9-oxidoreductase inhibitor | ChEBI |
| 9-keto-prostaglandin E2 reductase inhibitor | ChEBI |
| prostaglandin E2-9-oxoreductase inhibitors | ChEBI |
| reductase, 15-hydroxy-9-oxoprostaglandin inhibitor | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Prostaglandin-E2_9-reductase | Wikipedia |